Berlin, Germany

Norbert Schwarz

This inventor holds 17 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1980-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norbert Schwarz. Retrieved from https://idiyas.com/inventor/norbert-schwarz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 164(Granted Patents)


Company Filing History:


Years Active: 1980-1992

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Norbert Schwarz: Innovator in Carbacyclins

Introduction

Norbert Schwarz is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of chemistry, particularly in the development of carbacyclins. With a total of 17 patents to his name, Schwarz has established himself as a key figure in innovation.

Latest Patents

One of his latest patents focuses on carbacyclins, detailing a process for their preparation and use. The invention relates to carbacyclins of general Formula I, wherein R₁ is the residue CH₂OH or other specified residues, and R₂ can represent various chemical groups. Additionally, the patent includes 11-haloprostane derivatives, which are crucial for further applications in the field.

Career Highlights

Throughout his career, Norbert Schwarz has been associated with Schering Aktiengesellschaft, a leading pharmaceutical company. His work has not only advanced scientific knowledge but has also contributed to practical applications in medicine and pharmacology.

Collaborations

Schwarz has collaborated with notable colleagues, including Werner Skuballa and Olaf Loge. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Norbert Schwarz's contributions to the field of carbacyclins and his extensive patent portfolio highlight his role as a significant inventor. His work continues to influence advancements in chemistry and pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…